Solubility measurement for famoxadone polymorphs
An excess amount of famoxadone polymorphs was added to 15 mL of the corresponding mixed solvent system and was left to stir overnight at 30 ± 1 °C. The saturated solution was filtered through a 0.22-μm syringe filter, and then, 10.0 mL of the clear solution were transferred to a preweighed vial. The solution was left to evaporate at room temperature and weighed, and famoxadone solubility was calculated. The XRPD patterns of the filtrate were recorded to ensure that the solubility of the desired polymorph was determined. To determine the solubility of Form II, a certain amount of solvent was introduced to the vessel previously, and then, preweighed solute was added. The solution was stirred continuously at 200 rpm under 30 °C. The solute was added repeatedly until it could not be dissolved completely within 30 min. Finally, the solution was regarded as a saturated one. The total addition was recorded, and the range of the solubility could be determined.
Two parallel experiments of solubility measurements were performed.
Slurry Experiment for famoxadone transformation
The slurry experiment was investigated in the corresponding mixed solvent system. For each experiment, about 60 mL of saturated solution of Form I, prepared under set temperatures, was added to the vessel, and then, preweighed Form II was added.
The agitation speed was set at 200 rpm, and the system temperature was investigated by a detector. In addition, it was assumed that the insertion of PAT analyzers had no influence on the nature of the polymorphic transformation mechanism.
Quantitative phase analysis
The calibration curve of the famoxadone Form I and Form II mixture is given in Figure S10 . The homogenous composition of the analyzed mixtures and the S3 equivalent extinction effects for both polymorphs could ensure that the diffraction peak intensity of each phase depends linearly on the phase weight fractions in the sample. Nevertheless, experimental data can be described by the linear equation y = 1.00785x0.16369 with an R 2 value of 0.9991.
Table S1
Data of peaks in the PXRD patterns of famoxadone Form I. 
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